SPY408.32+8.23 2.06%
DIA327.10+4.32 1.34%
IXIC11,984.52+321.73 2.76%

--HC Wainwright Adjusts Alnylam Pharmaceuticals' Price Target to $430 from $400, Keeps Buy Rating

MT Newswires · 05/02/2022 07:11

Please log in to view news